Ginkgo Bioworks Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	167.2	561.57	944.07	1,316	1,550
Short-Term Investments	255.42	-	-	-	-
Cash & Short-Term Investments	422.62	561.57	944.07	1,316	1,550
Cash Growth	-24.74%	-40.52%	-28.25%	-15.11%	307.04%
Accounts Receivable	24.26	22.44	17.9	82.47	136.14
Other Receivables	-	-	-	1.56	-
Receivables	24.26	22.44	30.19	84.03	147.7
Inventory	-	-	-	4.36	3.51
Prepaid Expenses	17.93	12.89	22.7	35.11	18.94
Restricted Cash	7.03	5.84	4.79	8.22	-
Other Current Assets	-	-	-	2.57	2.9
Total Current Assets	471.84	602.74	1,002	1,450	1,723
Property, Plant & Equipment	528.7	598.16	394.99	718.79	145.77
Long-Term Investments	15.07	48.7	78.57	113.73	115.23
Goodwill	-	-	49.24	60.21	21.31
Other Intangible Assets	56.92	72.51	82.74	111.04	21.64
Other Long-Term Assets	40.04	41.17	44.45	47.81	43.99
Total Assets	1,120	1,377	1,665	2,539	2,071
Accounts Payable	10.57	14.17	9.32	10.45	8.19
Accrued Expenses	15.57	19.19	49.87	52.3	85.14
Current Portion of Leases	22.81	28.97	17.47	29.33	0.75
Current Unearned Revenue	35.9	30.6	48.5	47.82	33.24
Other Current Liabilities	11.13	14.34	38.7	33.06	7.45
Total Current Liabilities	95.97	107.27	163.86	172.96	134.76
Long-Term Leases	417.08	438.77	221.84	413.26	22.28
Long-Term Unearned Revenue	75.18	98.78	158.06	174.77	155.99
Other Long-Term Liabilities	22.88	16.58	24.43	42.06	190.58
Total Liabilities	611.11	661.39	568.19	803.04	503.61
Common Stock	0.01	0.01	0.01	0.19	0.16
Additional Paid-In Capital	6,657	6,555	6,386	6,136	3,805
Retained Earnings	-6,150	-5,838	-5,291	-4,398	-2,298
Comprehensive Income & Other	1.85	-1.81	1.48	-2.63	-1.72
Total Common Equity	508.59	716.06	1,097	1,736	1,505
Minority Interest	-	-	-	-	62.01
Shareholders' Equity	508.59	716.06	1,097	1,736	1,567
Total Liabilities & Equity	1,120	1,377	1,665	2,539	2,071
Total Debt	439.89	467.73	239.31	442.59	23.03
Net Cash (Debt)	-17.27	93.84	704.76	873.2	1,527
Net Cash Growth	-	-86.69%	-19.29%	-42.81%	319.73%
Net Cash Per Share	-0.31	1.81	14.50	20.79	44.90
Filing Date Shares Outstanding	58.21	54.37	50.03	51.81	43.99
Total Common Shares Outstanding	58.21	54.37	50.03	47.3	40.28
Working Capital	375.87	495.48	837.89	1,277	1,588
Book Value Per Share	8.74	13.17	21.93	36.71	37.37
Tangible Book Value	451.67	643.55	965.17	1,565	1,462
Tangible Book Value Per Share	7.76	11.84	19.29	33.09	36.30
Land	6.06	6.06	6.06	6.06	-
Buildings	49.76	48.26	47.03	-	-
Machinery	161.86	172.33	168.42	206.72	128.75
Construction In Progress	0.19	1.98	15.83	23.43	10.28
Leasehold Improvements	140.51	135.96	71.56	125.31	55.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.